Robert A. Lenz
Director · 3 filings · Latest: Aug 22, 2026
LB PHARMACEUTICALS INC
NovaBridge Biosciences
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NBP | Robert A. Lenz | Director | Aug 22, 2026 | Option Exercise | — | 17,218 | — | 17,218 | |
NMRA | Lenz Robert A. | — | Feb 18, 2025 | Proposed Sale | $1.67 | 5,614 | $9.4K | — | |
NMRA | Lenz Robert A. | — | Oct 10, 2024 | Proposed Sale | $15.09 | 8,260 | $124.6K | — | |
NMRA | Lenz Robert A. | — | Oct 9, 2024 | Proposed Sale | $15.01 | 5,563 | $83.5K | — | |
NMRA | Lenz Robert A. | — | Sep 18, 2024 | Proposed Sale | $12.09 | 10,676 | $129.1K | — | |
NMRA | Lenz Robert A. | — | Sep 17, 2024 | Proposed Sale | $11.81 | 30,788 | $363.7K | — | |
NMRA | Lenz Robert A. | — | Sep 12, 2024 | Proposed Sale | $11.43 | 32,948 | $376.7K | — |